Master Alliance Provisions Guide (MAPGuide)

DNDi Template Development Collaboration and License Agreement

  • Business model | Benefit sharing

<p>&#8220;<strong>PRVstrong>&#8221; shall mean the Food and Drug Administration (“FDA”) priority review voucher program in the United States of America.p>
<p>&#8220;<strong>Regulatory Advantagestrong>&#8221; shall mean the PRV or any equivalent incentive program to the PRV from a <a href=”#kt“>Regulatory Authoritya> regarding a Product.p>
<p><span style=”textdecoration: underline;”><strong>8. REGULATORY ADVANTAGEstrong>span>p>
<p><strong>8.1strong> The Parties acknowledge that both Parties will actively contribute to the Development and Distribution Program and agree to share the economic benefits of any Regulatory Advantage.p>
<p><strong>8.2strong> In the event Partner (or any of its Affiliates) obtains a Regulatory Advantage from the <a href=”#kt“>Marketing Authorisationa> of a Product: a) &lt; to complete &gt;p>